The purpose of this study is to investigate metastatic pancreatic cancer. It looks at how the condition responds to different treatments.
This study evaluates the combination of therapies to see how effective and safe they are. It focuses on understanding the impact on survival rates and disease progression.
- Who can participate: Adults aged 18 and older with metastatic pancreatic adenocarcinoma can join. Participants need to have measurable tumors and meet specific health criteria.
- Study details: Participants will receive a combination of treatments, including standard chemotherapy and a device that uses radiofrequency electromagnetic fields. Some may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.